In vivo effects of interleukin‐11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis
- 1 August 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 90 (4) , 783-790
- https://doi.org/10.1111/j.1365-2141.1995.tb05196.x
Abstract
Summary. In this study we evaluated the in vivo effects of interleukin‐11 (IL‐11) and stem cell factor (SCF), in combination with erythropoietin (EPO) on murine erythropoiesis. Mice were treated for 7d with IL‐11, SCF and EPO, each at three dose levels. In total, 27 different dose combinations were tested. IL‐11 as well as SCF could only marginally stimulate erythroid progenitor cell numbers, but IL‐11 in combination with SCF was able to increase BFU‐E and CFU‐E numbers 4‐fold, in the absence of exogenous EPO. This resulted in an increased reticulocyte count. In contrast with the stimulatory effect on immature erythroid cell stages, IL‐11 treatment induced a mild anaemia, which probably resulted from a plasma volume expansion. The additional treatment with EPO resulted in strong synergistic effects on CFU‐E numbers. The combination of high‐dose IL‐11 and high‐dose SCF was able to increase the overall efficiency of EPO‐induced erythroid amplification, which was reflected by a left‐shift of the in vivo EPO dose‐response curve. The stimulating effects of IL‐11 and SCF were further demonstrated when the effects on the reticulocyte count of a single high‐dose EPO injection were assessed in normal and SCF + IL‐11 treated mice. Whereas a single EPO dose increased the reticulocyte count by a factor of 3, IL‐11 + SCF pretreatment increased this to a factor of 7. This study shows that in vivo SCF and IL‐11 are important modulators of red blood cell production. First, these factors probably increase the input from the stem cell compartment into the erythroid lineage, where subsequently EPO is required for further amplification. Additionally, however, IL‐11 and SCF increase the overall efficiency of EPO‐induced amplification, probably due to a stimulatory effect on late‐stage erythroid cells and to a redistribution of cells from marrow to spleen.Keywords
This publication has 28 references indexed in Scilit:
- Effects of continuous stem cell factor administration on normal and erythropoietin‐stimulated murine hemopoiesis: Experimental results and model analysisThe International Journal of Cell Cloning, 1995
- Apoptosis of human erythroid colony‐forming cells is decreased by stem cell factor and insulin‐like growth factor I as well as erythropoietinJournal of Cellular Physiology, 1993
- Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.Proceedings of the National Academy of Sciences, 1992
- Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors.Proceedings of the National Academy of Sciences, 1991
- The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells.The Journal of Experimental Medicine, 1991
- Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture.Proceedings of the National Academy of Sciences, 1991
- Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.Proceedings of the National Academy of Sciences, 1990
- Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor CellsScience, 1990
- Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats.Proceedings of the National Academy of Sciences, 1988
- The Distribution of Erythropoietic Bone Marrow in the MouseActa Haematologica, 1970